- Home
- VLY vs VTAK Comparison
VLY vs VTAK Comparison
Compare VLY & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLY
- VTAK
- Stock Information
- Founded
- VLY 1927
- VTAK 2002
- Country
- VLY United States
- VTAK United States
- Employees
- VLY N/A
- VTAK N/A
- Industry
- VLY Major Banks
- VTAK Medical/Dental Instruments
- Sector
- VLY Finance
- VTAK Health Care
- Exchange
- VLY Nasdaq
- VTAK Nasdaq
- Market Cap
- VLY N/A
- VTAK 1.1M
- IPO Year
- VLY N/A
- VTAK 2018
- Fundamental
- Price
- VLY $8.87
- VTAK $0.35
- Analyst Decision
- VLY Hold
- VTAK
- Analyst Count
- VLY 10
- VTAK 0
- Target Price
- VLY $8.50
- VTAK N/A
- AVG Volume (30 Days)
- VLY 6.2M
- VTAK 236.7K
- Earning Date
- VLY 10-24-2024
- VTAK 08-14-2024
- Dividend Yield
- VLY 4.96%
- VTAK N/A
- EPS Growth
- VLY N/A
- VTAK N/A
- EPS
- VLY 0.71
- VTAK N/A
- Revenue
- VLY $1,654,551,000.00
- VTAK $436,000.00
- Revenue This Year
- VLY N/A
- VTAK $637.10
- Revenue Next Year
- VLY $7.31
- VTAK $177.13
- P/E Ratio
- VLY $12.49
- VTAK N/A
- Revenue Growth
- VLY N/A
- VTAK 140.88
- 52 Week Low
- VLY $6.47
- VTAK $0.31
- 52 Week High
- VLY $11.22
- VTAK $8.40
- Technical
- Relative Strength Index (RSI)
- VLY 52.48
- VTAK 26.19
- Support Level
- VLY $8.73
- VTAK $0.35
- Resistance Level
- VLY $9.08
- VTAK $0.35
- Average True Range (ATR)
- VLY 0.25
- VTAK 0.04
- MACD
- VLY -0.03
- VTAK 0.04
- Stochastic Oscillator
- VLY 36.29
- VTAK 9.57
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.